Irinotecan, Carboplatin, Bevacizumab, and Radiation Therapy in the Treatment of Limited Stage Small Cell Lung Cancer

NCT00308529 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

55

Enrollment

OTHER

Sponsor class

Conditions

Carcinoma, Small Cell Lung
Lung Cancer

Interventions

DRUG: irinotecan
DRUG: carboplatin
DRUG: bevacizumab
PROCEDURE: Radiation Therapy

Sponsor

SCRI Development Innovations, LLC

Collaborators

[object Object]